{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T01:30:49Z","timestamp":1792287049338,"version":"4.4.0"},"reference-count":137,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2019,1,23]],"date-time":"2019-01-23T00:00:00Z","timestamp":1548201600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Calcif Tissue Int"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1007\/s00223-019-00522-3","type":"journal-article","created":{"date-parts":[[2019,1,24]],"date-time":"2019-01-24T04:39:35Z","timestamp":1548304775000},"page":"483-500","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":98,"title":["Paget\u2019s Disease of Bone"],"prefix":"10.1007","volume":"104","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6833-4232","authenticated-orcid":false,"given":"Luigi","family":"Gennari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Domenico","family":"Rendina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Falchetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3338-6339","authenticated-orcid":false,"given":"Daniela","family":"Merlotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,1,23]]},"reference":[{"key":"522_CR1","volume-title":"Pathophysiology and treatment of Paget\u2019s disease of bone","author":"JA Kanis","year":"1992","unstructured":"Kanis JA (1992) Pathophysiology and treatment of Paget\u2019s disease of bone, 2nd\u00a0edn. Martin Dunitz, London","edition":"2"},{"key":"522_CR2","first-page":"37","volume":"60","author":"J Paget","year":"1876","unstructured":"Paget J (1876) On a form of chronic inflammation of bones (osteitis deformans). Med Chir Trans 60:37\u201363","journal-title":"Med Chir Trans"},{"key":"522_CR3","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1080\/21678707.2018.1500691","volume":"8","author":"L Gennari","year":"2018","unstructured":"Gennari L, Rendina D, Picchioni T, Bianciardi S, Materozzi M, Nuti R, Merlotti D (2018) Paget\u2019s disease of bone: an update on epidemiology, pathogenesis and pharmacotherapy. Expert Opin Orphan Drugs 8:485\u2013496. https:\/\/doi.org\/10.1080\/21678707.2018.1500691","journal-title":"Expert Opin Orphan Drugs"},{"key":"522_CR4","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1136\/bmj.285.6347.1005","volume":"285","author":"FM Detheridge","year":"1982","unstructured":"Detheridge FM, Guyer PB, Barker DJ (1982) European distribution of Paget\u2019s disease of bone. Br Med J 285:1005\u20131008","journal-title":"Br Med J"},{"key":"522_CR5","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/S0009-9260(88)80341-6","volume":"39","author":"PB Guyer","year":"1988","unstructured":"Guyer PB, Chamberlain AT (1988) Paget\u2019s disease of bone in South Africa. Clin Radiol 39:51\u201352","journal-title":"Clin Radiol"},{"key":"522_CR6","doi-asserted-by":"publisher","first-page":"P3","DOI":"10.1359\/jbmr.06s201","volume":"21","author":"C Cooper","year":"2006","unstructured":"Cooper C, Harvey NC, Dennison EM, van Staa TP (2006) Update on the epidemiology of Paget\u2019s disease of bone. J Bone Miner Res 21:P3\u2013P8","journal-title":"J Bone Miner Res"},{"key":"522_CR7","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/0221-8747(81)90037-0","volume":"3","author":"DJ Barker","year":"1981","unstructured":"Barker DJ (1981) The epidemiology of Paget\u2019s disease. Metab Bone Dis Relat Res 3:231\u2013233","journal-title":"Metab Bone Dis Relat Res"},{"issue":"3","key":"522_CR8","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1359\/jbmr.2000.15.3.461","volume":"15","author":"RD Altman","year":"2000","unstructured":"Altman RD, Bloch DA, Hochberg MC, Murphy WA (2000) Prevalence of pelvic Paget\u2019s disease of bone in the United States. J Bone Miner Res 15(3):461\u2013465","journal-title":"J Bone Miner Res"},{"key":"522_CR9","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1359\/jbmr.2002.17.3.465","volume":"17","author":"TP Staa van","year":"2002","unstructured":"van Staa TP, Selby P, Leufkens HG, Lyles K, Sprafka JM, Cooper C (2002) Incidence and natural history of Paget\u2019s disease of bone in England and Wales. J Bone Miner Res 17:465\u2013471. https:\/\/doi.org\/10.1359\/jbmr.2002.17.3.465","journal-title":"J Bone Miner Res"},{"key":"522_CR10","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1136\/bmj.280.6222.1105","volume":"280","author":"DJ Barker","year":"1980","unstructured":"Barker DJ, Chamberlain AT, Guyer PB, Gardner MJ (1980) Paget\u2019s disease of bone: the Lancashire focus. Br Med J 280:1105\u20131107","journal-title":"Br Med J"},{"key":"522_CR11","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1359\/jbmr.1999.14.2.192","volume":"14","author":"C Cooper","year":"1999","unstructured":"Cooper C, Schafheutle K, Dennison E, Kellingray S, Guyer P, Barker D (1999) The epidemiology of Paget\u2019s disease in Britain: is the prevalence decreasing? J Bone Miner Res 14:192\u2013197","journal-title":"J Bone Miner Res"},{"key":"522_CR12","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/S8756-3282(96)00310-9","volume":"20","author":"T Cundy","year":"1997","unstructured":"Cundy T, McAnulty K, Wattie D, Gamble G, Rutland M, Ibbertson HK (1997) Evidence for secular change in Paget\u2019s disease. Bone 20:69\u201371","journal-title":"Bone"},{"key":"522_CR13","first-page":"635","volume":"21","author":"G Lopez-Abente","year":"2003","unstructured":"Lopez-Abente G, Morales-Piga A, Bachiller-Corral FJ, Illera-Mart\u00edn O, Mart\u00edn-Domenech R, Abraira V (2003) Identification of possible areas of high prevalence of Paget\u2019s disease of bone in Spain. Clin Exp Rheumatol 21:635\u2013638","journal-title":"Clin Exp Rheumatol"},{"key":"522_CR14","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.1359\/JBMR.050322","volume":"20","author":"D Merlotti","year":"2005","unstructured":"Merlotti D, Gennari L, Galli B, Martini G, Calabr\u00f2 A, De Paola V, Ceccarelli E, Nardi P, Avanzati A, Nuti R (2005) Characteristics and familial aggregation of Paget\u2019s disease of bone in Italy. J Bone Miner Res 20:1356\u20131364. https:\/\/doi.org\/10.1359\/JBMR.050322","journal-title":"J Bone Miner Res"},{"key":"522_CR15","doi-asserted-by":"publisher","first-page":"1845","DOI":"10.1359\/JBMR.050518","volume":"20","author":"L Gennari","year":"2005","unstructured":"Gennari L, Di Stefano M, Merlotti D, Giordano N, Martini G, Tamone C, Zatteri R, De Lucchi R, Baldi C, Vattimo A, Capoccia S, Burroni L, Geraci S, De Paola V, Calabr\u00f2 A, Avanzati A, Isaia G, Nuti R (2005) Prevalence of Paget\u2019s disease of bone in Italy. J Bone Miner Res 20:1845\u20131850","journal-title":"J Bone Miner Res"},{"key":"522_CR16","doi-asserted-by":"publisher","first-page":"P14","DOI":"10.1359\/jbmr.06s203","volume":"21","author":"L Gennari","year":"2006","unstructured":"Gennari L, Merlotti D, Martini G, Nuti R (2006) Paget\u2019s disease of bone in Italy. J Bone Miner Res 21:P14\u2013P21","journal-title":"J Bone Miner Res"},{"key":"522_CR17","doi-asserted-by":"publisher","first-page":"1828","DOI":"10.1359\/jbmr.060822","volume":"21","author":"D Rendina","year":"2006","unstructured":"Rendina D, Gennari L, De Filippo G, Merlotti D, de Campora E, Fazioli F, Scarano G, Nuti R, Strazzullo P, Mossetti G (2006) Evidence for increased clinical severity of familial and sporadic Paget\u2019s disease of bone in Campania, southern Italy. J Bone Miner Res 21:1828\u20131835","journal-title":"J Bone Miner Res"},{"key":"522_CR18","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1007\/s00198-012-1954-5","volume":"24","author":"L Corral-Gudino","year":"2013","unstructured":"Corral-Gudino L, Garcia-Aparicio J, Sanchez-Gonzalez MD, Mir\u00f3n-Canelo JA, Blanco JF, Ralston SH, del Pino-Montes J (2013) Secular changes in Paget\u2019s disease: contrasting changes in the number of new referrals and in disease severity in two neighboring regions of Spain. Osteoporos Int 24:443\u2013450. https:\/\/doi.org\/10.1007\/s00198-012-1954-5","journal-title":"Osteoporos Int"},{"key":"522_CR19","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1093\/rheumatology\/kex505","volume":"57","author":"O Abdulla","year":"2018","unstructured":"Abdulla O, Naqvi MJ, Shamshuddin S, Bukhari M, Proctor R (2018) Prevalence of Paget\u2019s disease of bone in Lancaster: time for an update. Rheumatology 57:931\u2013932. https:\/\/doi.org\/10.1093\/rheumatology\/kex505","journal-title":"Rheumatology"},{"key":"522_CR20","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1002\/jbmr.5650140203","volume":"14","author":"SV Reddy","year":"1999","unstructured":"Reddy SV, Menaa C, Singer FR, Demulder A, Roodman GD (1999) Cell biology of Paget\u2019s disease. J Bone Miner Res 14:3\u20138","journal-title":"J Bone Miner Res"},{"key":"522_CR21","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1002\/jbmr.5650140204","volume":"14","author":"PG Robey","year":"1999","unstructured":"Robey PG, Bianco P (1999) The role of osteogenic cells in the pathophysiology of Paget\u2019s disease. J Bone Miner Res 14:9\u201316","journal-title":"J Bone Miner Res"},{"issue":"Suppl 2","key":"522_CR22","doi-asserted-by":"publisher","first-page":"P51","DOI":"10.1359\/jbmr.06s209","volume":"21","author":"FR Singer","year":"2006","unstructured":"Singer FR, Mills BG, Gruber HE, Windle JJ, Roodman GD (2006) Ultrastructure of bone cells in Paget\u2019s disease of bone. J Bone Miner Res 21(Suppl 2):P51\u2013P54","journal-title":"J Bone Miner Res"},{"issue":"2","key":"522_CR23","doi-asserted-by":"publisher","first-page":"85","DOI":"10.11005\/jbm.2014.21.2.85","volume":"21","author":"DL Galson","year":"2014","unstructured":"Galson DL, Roodman GD (2014) Pathobiology of Paget\u2019s disease of bone. J Bone Metab 21(2):85\u201398","journal-title":"J Bone Metab"},{"key":"522_CR24","doi-asserted-by":"publisher","first-page":"1978","DOI":"10.1210\/endo.133.5.7691583","volume":"133","author":"A Demulder","year":"1993","unstructured":"Demulder A, Takahashi S, Singer FR, Hosking DJ, Roodman GD (1993) Abnormalities in osteoclast precursors and the marrow microenvironment in Paget\u2019s disease. Endocrinology 133:1978\u20131982. https:\/\/doi.org\/10.1210\/endo.133.5.7691583","journal-title":"Endocrinology"},{"key":"522_CR25","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1097\/00003086-198704000-00012","volume":"217","author":"B Maldague","year":"1987","unstructured":"Maldague B, Malghem J (1987) Dynamic radiologic patterns of Paget\u2019s disease of bone. Clin Orthop Relat Res 217:126\u2013151","journal-title":"Clin Orthop Relat Res"},{"key":"522_CR26","first-page":"985","volume-title":"Disorders of bone and mineral metabolism","author":"RD Altman","year":"2002","unstructured":"Altman RD (2002) In: Coe FL, Favus MJ (eds) Disorders of bone and mineral metabolism. 2nd\u00a0edn. Lippincott Williams & Wilkins, Philadelphia, pp\u00a0985\u20131020","edition":"2"},{"key":"522_CR27","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1007\/s00223-014-9904-1","volume":"95","author":"A Tan","year":"2014","unstructured":"Tan A, Ralston SH (2014) Clinical presentation of Paget\u2019s disease: evaluation of a contemporary cohort and systematic review. Calcif Tissue Int 95:385\u2013392. https:\/\/doi.org\/10.1007\/s00223-014-9904-1","journal-title":"Calcif Tissue Int"},{"key":"522_CR28","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1002\/jbmr.5650140217","volume":"14","author":"RD Altman","year":"1999","unstructured":"Altman RD (1999) Arthritis in Paget\u2019s disease of bone. J Bone Miner Res 14:85\u201387","journal-title":"J Bone Miner Res"},{"key":"522_CR29","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1097\/00003086-198704000-00006","volume":"217","author":"PJ Meunier","year":"1987","unstructured":"Meunier PJ, Salson C, Mathieu L, Chapuy MC, Delmas P, Alexandre C, Charhon S (1987) Skeletal distribution and biochemical parameters of Paget\u2019s disease. Clin Orthop Relat Res 217:37\u201344","journal-title":"Clin Orthop Relat Res"},{"key":"522_CR30","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1002\/jbmr.5650140218","volume":"14","author":"A Poncelet","year":"1999","unstructured":"Poncelet A (1999) The neurologic complications of Paget\u2019s disease. J Bone Miner Res 14:88\u201391","journal-title":"J Bone Miner Res"},{"key":"522_CR31","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1002\/jbmr.5650140219","volume":"14","author":"EM Monsell","year":"1999","unstructured":"Monsell EM, Cody DD, Bone HG, Divine GW (1999) Hearing loss as a complication of Paget\u2019s disease of bone. J Bone Miner Res 14:92\u201395","journal-title":"J Bone Miner Res"},{"key":"522_CR32","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.2106\/00004623-199173090-00013","volume":"73","author":"A Hadjipavlou","year":"1991","unstructured":"Hadjipavlou A, Lander P (1991) Paget disease of the spine. J Bone Joint Surg Am 73:1376\u20131381","journal-title":"J Bone Joint Surg Am"},{"issue":"12","key":"522_CR33","doi-asserted-by":"publisher","first-page":"2050","DOI":"10.1093\/rheumatology\/kew430","volume":"56","author":"PS Tuck","year":"2017","unstructured":"Tuck PS, Layfield R, Walker J, Mekkayil B, Francis R (2017) Adult Paget\u2019s disease of bone: a review. Rheumatology 56(12):2050\u20132059","journal-title":"Rheumatology"},{"key":"522_CR34","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1016\/0002-9343(87)90157-4","volume":"82","author":"SA Strickenberger","year":"1987","unstructured":"Strickenberger SA, Schulman SP, Hutchins GM (1987) Association of Paget\u2019s disease of bone with calcific aortic valve disease. Am J Med 82:953\u2013956","journal-title":"Am J Med"},{"key":"522_CR35","doi-asserted-by":"publisher","first-page":"1442","DOI":"10.1002\/1097-0142(19860401)57:7<1442::AID-CNCR2820570734>3.0.CO;2-3","volume":"57","author":"AG Huvos","year":"1986","unstructured":"Huvos AG (1986) Osteogenic sarcoma of bones and soft tissues in older persons. A clinicopathologic analysis of 117 patients older than 60 years. Cancer 57:1442\u20131449","journal-title":"Cancer"},{"key":"522_CR36","doi-asserted-by":"publisher","first-page":"P58","DOI":"10.1359\/jbmr.06s211","volume":"21","author":"MF Hansen","year":"2006","unstructured":"Hansen MF, Seton M, Merchant A (2006) Osteosarcoma in Paget\u2019s disease of bone. J Bone Miner Res 21:P58\u2013P63","journal-title":"J Bone Miner Res"},{"key":"522_CR37","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1002\/jbmr.2349","volume":"30","author":"D Rendina","year":"2015","unstructured":"Rendina D, De Filippo G, Ralston SH, Merlotti D, Gianfrancesco F, Esposito T, Muscariello R, Nuti R, Strazzullo P, Gennari L (2015) Clinical characteristics and evolution of giant cell tumor occurring in Paget\u2019s disease of bone. J Bone Miner Res 30:257\u2013263. https:\/\/doi.org\/10.1002\/jbmr.2349","journal-title":"J Bone Miner Res"},{"key":"522_CR38","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1210\/jcem-65-1-89","volume":"65","author":"SE Papapoulos","year":"1987","unstructured":"Papapoulos SE, Frolich M, Mudde AH, Harinck HI, vd Berg H, Bijvoet OL (1987) Serum osteocalcin in Paget\u2019s disease of bone: basal concentrations and response to bisphosphonate treatment. J Clin Endocrinol Metab 65:89\u201394","journal-title":"J Clin Endocrinol Metab"},{"key":"522_CR39","doi-asserted-by":"publisher","first-page":"4408","DOI":"10.1210\/jc.2014-2910","volume":"99","author":"FR Singer","year":"2014","unstructured":"Singer FR, Bone HG 3rd, Hosking DJ, Lyles KW, Murad MH, Reid IR, Siris ES, Endocrine Society (2014) Paget\u2019s disease of bone: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 99:4408\u20134422. https:\/\/doi.org\/10.1210\/jc.2014-2910","journal-title":"J Clin Endocrinol Metab"},{"key":"522_CR40","first-page":"133","volume":"58","author":"HI Harinck","year":"1986","unstructured":"Harinck HI, Bijvoet OL, Vellenga CJ, Blanksma HJ, Frijlink WB (1986) Relation between signs and symptoms in Paget\u2019s disease of bone. Q J Med 58:133\u2013151","journal-title":"Q J Med"},{"key":"522_CR41","doi-asserted-by":"publisher","first-page":"1875","DOI":"10.1007\/s00198-015-3095-0","volume":"26","author":"AA Al Nofal","year":"2015","unstructured":"Al Nofal AA, Altayar O, BenKhadra K, Qasim Agha OQ, Asi N, Nabhan M, Prokop LJ, Tebben P, Murad MH (2015) Bone turnover markers in Paget\u2019s disease of the bone: a systematic review and meta-analysis. Osteoporos Int 26:1875\u20131891. https:\/\/doi.org\/10.1007\/s00198-015-3095-0","journal-title":"Osteoporos Int"},{"key":"522_CR42","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1359\/jbmr.2004.19.4.566","volume":"19","author":"ME Eekhoff","year":"2004","unstructured":"Eekhoff ME, van der Klift M, Kroon HM, Cooper C, Hofman A, Pols HA, Papapoulos SE (2004) Paget\u2019s disease of bone in The Netherlands: a population-based radiological and biochemical survey\u2014the Rotterdam study. J Bone Miner Res 19:566\u2013570","journal-title":"J Bone Miner Res"},{"key":"522_CR43","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1002\/jbmr.5650100318","volume":"10","author":"L Alvarez","year":"1995","unstructured":"Alvarez L, Guanabens N, Peris P, Monegal A, Bedini JL, Deulofeu R, Martinez de Osaba MJ, Mu\u00f1oz-Gomez J, Rivera-Fillat F, Ballesta AM (1995) Discriminative value of biochemical markers of bone turnover in assessing the activity of Paget\u2019s disease. J Bone Miner Res 10:458\u2013465","journal-title":"J Bone Miner Res"},{"key":"522_CR44","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1002\/art.1780400312","volume":"40","author":"L Alvarez","year":"1997","unstructured":"Alvarez L, Peris P, Pons F, Guanabens N, Herranz R, Monegal A, Bedini JL, Deulofeu R, Mart\u00ednez de Osaba MJ, Mu\u00f1oz-G\u00f3mez J, Ballesta AM (1997) Relationship between biochemical markers of bone turnover and bone scintigraphic indices in assessment of Paget\u2019s disease activity. Arthritis Rheum 40:461\u2013468","journal-title":"Arthritis Rheum"},{"key":"522_CR45","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1007\/s00223-012-9652-z","volume":"91","author":"N Guanabens","year":"2012","unstructured":"Guanabens N, Rotes D, Holgado S, Gobbo M, Descalzo MA, Gorordo JM, Mart\u00ednez-Ferrer MA, Salmoral A, Morales-Piga A (2012) Implications of a new radiological approach for the assessment of Paget disease. Calcif Tissue Int 91:409\u2013415. https:\/\/doi.org\/10.1007\/s00223-012-9652-z","journal-title":"Calcif Tissue Int"},{"key":"522_CR46","first-page":"417","volume":"5","author":"I Fogelman","year":"1980","unstructured":"Fogelman I, Carr D (1980) A comparison of bone scanning and radiology in the assessment of patients with symptomatic Paget\u2019s disease. Eur J Nucl Med 5:417\u2013421","journal-title":"Eur J Nucl Med"},{"key":"522_CR47","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1038\/nrendo.2015.138","volume":"11","author":"FR Singer","year":"2015","unstructured":"Singer FR (2015) Paget\u2019s disease of bone-genetic and environmental factors. Nat Rev Endocrinol 11:662\u2013671. https:\/\/doi.org\/10.1038\/nrendo.2015.138","journal-title":"Nat Rev Endocrinol"},{"key":"522_CR48","unstructured":"Ralston SH, Taylor JP Rare inherited Paget\u2019s disease like disorders. Calcif Tissue Int (in press)"},{"key":"522_CR49","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1016\/S0140-6736(02)24527-4","volume":"2","author":"A Pick","year":"1883","unstructured":"Pick A (1883) Osteitis deformans. Lancet 2:1125\u20131126","journal-title":"Lancet"},{"key":"522_CR50","first-page":"94","volume":"1","author":"MFA Montagu","year":"1949","unstructured":"Montagu MFA (1949) Paget\u2019s disease (osteitis deformans) and hereditary. Am J Hum Genet 1:94\u201395","journal-title":"Am J Hum Genet"},{"key":"522_CR51","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1002\/jbmr.5650060511","volume":"6","author":"ES Siris","year":"1991","unstructured":"Siris ES, Ottman R, Flaster E, Kelsey JL (1991) Familial aggregation of Paget\u2019s disease of bone. J Bone Miner Res 6:495\u2013500","journal-title":"J Bone Miner Res"},{"key":"522_CR52","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/0049-0172(94)90037-X","volume":"23","author":"ES Siris","year":"1994","unstructured":"Siris ES (1994) Epidemiological aspects of Paget\u2019s disease: family history and relationship to other medical conditions. Semin Arthritis Rheum 23:222\u2013225","journal-title":"Semin Arthritis Rheum"},{"key":"522_CR53","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1002\/jbmr.5650100421","volume":"10","author":"AA Morales-Piga","year":"1995","unstructured":"Morales-Piga AA, Rey-Rey JS, Corres-Gonz\u00e1lez J, Garc\u00eda-Sagredo JM, L\u00f3pez-Abente G (1995) Frequency and characteristics of familial aggregation of Paget\u2019s disease of bone. J Bone Miner Res 10:663\u2013670","journal-title":"J Bone Miner Res"},{"key":"522_CR54","doi-asserted-by":"publisher","DOI":"10.1002\/9780470015902.a0024396","volume-title":"Molecular genetics of Paget\u2019s disease of bone","author":"L Gennari","year":"2014","unstructured":"Gennari L, Gianfrancesco F, Rendina D, Merlotti D (2014) Molecular genetics of Paget\u2019s disease of bone. Wiley, Chichester. https:\/\/doi.org\/10.1002\/9780470015902.a0024396"},{"key":"522_CR55","doi-asserted-by":"publisher","first-page":"1582","DOI":"10.1086\/340731","volume":"70","author":"N Laurin","year":"2002","unstructured":"Laurin N, Brown JP, Morissette J, Raymond V (2002) Recurrent mutation of the gene encoding sequestosome 1 (SQSTM1\/p62) in Paget disease of bone. Am J Hum Genet 70:1582\u20131588. https:\/\/doi.org\/10.1086\/340731","journal-title":"Am J Hum Genet"},{"key":"522_CR56","doi-asserted-by":"publisher","first-page":"2735","DOI":"10.1093\/hmg\/11.22.2735","volume":"11","author":"LJ Hocking","year":"2002","unstructured":"Hocking LJ, Lucas GJ, Daroszewska A, Mangion J, Olavesen M, Cundy T, Nicholson GC, Ward L, Bennett ST, Wuyts W, Van Hul W, Ralston SH (2002) Domain specific mutations in Sequestosome 1 (SQSTM1) cause familial and sporadic Paget\u2019s disease. Hum Mol Genet 11:2735\u20132739","journal-title":"Hum Mol Genet"},{"key":"522_CR57","doi-asserted-by":"publisher","DOI":"10.1038\/bonekey.2015.125","author":"OM Albagha","year":"2015","unstructured":"Albagha OM (2015) Genetics of Paget\u2019s disease of bone. Bonekey Rep. https:\/\/doi.org\/10.1038\/bonekey.2015.125","journal-title":"Bonekey Rep"},{"key":"522_CR58","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/s00223-012-9599-0","volume":"91","author":"SH Ralston","year":"2012","unstructured":"Ralston SH, Layfield R (2012) Pathogenesis of Paget disease of bone. Calcif Tissue Int 91:97\u2013113","journal-title":"Calcif Tissue Int"},{"key":"522_CR59","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1210\/er.2012-1034","volume":"34","author":"SL Rea","year":"2013","unstructured":"Rea SL, Walsh JP, Layfield R, Ratajczak T, Xu J (2013) New insights into the role of sequestosome 1\/p62 mutant proteins in the pathogenesis of Paget\u2019s disease of bone. Endocr Rev 34:501\u2013524. https:\/\/doi.org\/10.1210\/er.2012-1034","journal-title":"Endocr Rev"},{"key":"522_CR60","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/S1534-5807(03)00403-9","volume":"6","author":"A Duran","year":"2004","unstructured":"Duran A, Serrano M, Leitges M, Flores JM, Picard S, Brown JP, Moscat J, Diaz-Meco MT (2004) The atypical PKC-interacting protein p62 is an important mediator of RANK-activated osteoclastogenesis. Dev Cell 6:303\u2013309","journal-title":"Dev Cell"},{"key":"522_CR61","doi-asserted-by":"publisher","first-page":"1858","DOI":"10.1172\/JCI34257","volume":"118","author":"W Jin","year":"2008","unstructured":"Jin W, Chang M, Paul EM, Babu G, Lee AJ, Reiley W, Wright A, Zhang M, You J, Sun SC (2008) Deubiquitinating enzyme CYLD negatively regulates RANK signaling and osteoclastogenesis in mice. J Clin Invest 118:1858\u20131866. https:\/\/doi.org\/10.1172\/JCI34257","journal-title":"J Clin Invest"},{"key":"522_CR62","doi-asserted-by":"publisher","first-page":"4180","DOI":"10.1210\/en.2011-1225","volume":"152","author":"K Sundaram","year":"2011","unstructured":"Sundaram K, Shanmugarajan S, Rao DS, Reddy SV (2011) Mutant p62P392L stimulation of osteoclast differentiation in Paget\u2019s disease of bone. Endocrinology 152:4180\u20134189. https:\/\/doi.org\/10.1210\/en.2011-1225","journal-title":"Endocrinology"},{"key":"522_CR63","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1172\/JCI28267","volume":"117","author":"N Kurihara","year":"2007","unstructured":"Kurihara N, Hiruma Y, Zhou H, Subler MA, Dempster DW, Singer FR, Reddy SV, Gruber HE, Windle JJ, Roodman GD (2007) Mutation of the sequestosome 1 (p62) gene increases osteoclastogenesis but does not induce Paget disease. J Clin Invest 117:133\u2013142. https:\/\/doi.org\/10.1172\/JCI28267","journal-title":"J Clin Invest"},{"key":"522_CR64","doi-asserted-by":"publisher","first-page":"3708","DOI":"10.1093\/hmg\/ddn266","volume":"17","author":"Y Hiruma","year":"2008","unstructured":"Hiruma Y, Kurihara N, Subler MA, Zhou H, Boykin CS, Zhang H, Ishizuka S, Dempster DW, Roodman GD, Windle JJ (2008) A SQSTM1\/p62 mutation linked to Paget\u2019s disease increases the osteoclastogenic potential of the bone microenvironment. Hum Mol Genet 17:3708\u20133719. https:\/\/doi.org\/10.1093\/hmg\/ddn266","journal-title":"Hum Mol Genet"},{"key":"522_CR65","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.cmet.2010.12.002","volume":"13","author":"N Kurihara","year":"2011","unstructured":"Kurihara N, Hiruma Y, Yamana K, Michou L, Rousseau C, Morissette J (2011) Contributions of the measles virus nucleocapsid gene and the SQSTM1\/p62(P392L) mutation to Paget\u2019s disease. Cell Metab 13:23\u201334","journal-title":"Cell Metab"},{"key":"522_CR66","doi-asserted-by":"publisher","first-page":"2734","DOI":"10.1093\/hmg\/ddr172","volume":"20","author":"A Daroszewska","year":"2011","unstructured":"Daroszewska A, van \u2018t Hof RJ, Rojas JA, Layfield R, Landao-Basonga E, Rose L, Rose K, Ralston SH (2011) A point mutation in the ubiquitin-associated domain of SQSMT1 is sufficient to cause a Paget\u2019s disease-like disorder in mice. Hum Mol Genet 20:2734\u20132744. https:\/\/doi.org\/10.1093\/hmg\/ddr172","journal-title":"Hum Mol Genet"},{"key":"522_CR67","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1002\/jbmr.31","volume":"25","author":"L Gennari","year":"2010","unstructured":"Gennari L, Gianfrancesco F, Di Stefano M, Rendina D, Merlotti D, Esposito T, Gallone S, Fusco P, Rainero I, Fenoglio P, Mancini M, Martini G, Bergui S, De Filippo G, Isaia G, Strazzullo P, Nuti R, Mossetti G (2010) SQSTM1 gene analysis and gene-environment interaction in Paget\u2019s disease of bone. J Bone Miner Res 25:1375\u20131384. https:\/\/doi.org\/10.1002\/jbmr.31","journal-title":"J Bone Miner Res"},{"key":"522_CR68","doi-asserted-by":"publisher","first-page":"2368","DOI":"10.1002\/jbmr.132","volume":"25","author":"MR Visconti","year":"2010","unstructured":"Visconti MR, Langston AL, Alonso N, Goodman K, Selby PL, Fraser WD, Ralston SH (2010) Mutations of SQSTM1 are associated with severity and clinical outcome in Paget\u2019s disease of bone. J Bone Miner Res 25:2368\u20132373. https:\/\/doi.org\/10.1002\/jbmr.132","journal-title":"J Bone Miner Res"},{"key":"522_CR69","doi-asserted-by":"publisher","first-page":"2338","DOI":"10.1002\/jbmr.1975","volume":"28","author":"OM Albagha","year":"2013","unstructured":"Albagha OM, Visconti MR, Alonso N, Wani S, Goodman K, Fraser WD, Gennari L, Merlotti D, Gianfrancesco F, Esposito T, Rendina D, di Stefano M, Isaia G, Brandi ML, Giusti F, Del Pino-Montes J, Corral-Gudino L, Gonzalez-Sarmiento R, Ward L, Rea SL, Ratajczak T, Walsh JP, Ralston SH (2013) Common susceptibility alleles and SQSTM1 mutations predict disease extent and severity in a multinational study of patients with Paget\u2019s disease. J Bone Miner Res 28:2338\u20132346. https:\/\/doi.org\/10.1002\/jbmr.1975","journal-title":"J Bone Miner Res"},{"key":"522_CR70","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1359\/JBMR.0403015","volume":"19","author":"LJ Hocking","year":"2004","unstructured":"Hocking LJ, Lucas GJA, Daroszewska A, Cundy T, Nicholson GC, Donath J, Walsh JP, Finlayson C, Cavey JR, Ciani B, Sheppard PW, Searle MS, Layfield R, Ralston SH (2004) Novel UBA domain mutations of SQSTM1 in Paget\u2019s disease of bone: genotype phenotype correlation, functional analysis and structural consequences. J Bone Miner Res 19:1122\u20131127. https:\/\/doi.org\/10.1359\/JBMR.0403015","journal-title":"J Bone Miner Res"},{"key":"522_CR71","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1016\/j.bbadis.2014.03.006","volume":"1842","author":"A Goode","year":"2014","unstructured":"Goode A, Long JE, Shaw B, Ralston SH, Visconti MR, Gianfrancesco F, Esposito T, Gennari L, Merlotti D, Rendina D, Rea SL, Sultana M, Searle MS, Layfield R (2014) Paget disease of bone-associated UBA domain mutations of SQSTM1 exert distinct effects on protein structure and function. Biochem Biophys Acta 1842:992\u20131000. https:\/\/doi.org\/10.1016\/j.bbadis.2014.03.006","journal-title":"Biochem Biophys Acta"},{"key":"522_CR72","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1038\/ng.562","volume":"42","author":"OM Albagha","year":"2010","unstructured":"Albagha OM, Visconti MR, Alonso N, Langston AL, Cundy T, Dargie R, Dunlop MG, Fraser WD, Hooper MJ, Isaia G, Nicholson GC, del Pino Montes J, Gonzalez-Sarmiento R, di Stefano M, Tenesa A, Walsh JP, Ralston SH (2010) Genome-wide association study identifies variants at CSF1, OPTN and TNFRSF11A as genetic risk factors for Paget\u2019s disease of bone. Nat Genet 42:520\u2013524. https:\/\/doi.org\/10.1038\/ng.562","journal-title":"Nat Genet"},{"key":"522_CR73","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1038\/ng.845","volume":"43","author":"OM Albagha","year":"2011","unstructured":"Albagha OM, Wani SE, Visconti MR, Alonso N, Goodman K, Brandi ML, Cundy T, Chung PY, Dargie R, Devogelaer JP, Falchetti A, Fraser WD, Gennari L, Gianfrancesco F, Hooper MJ, Van Hul W, Isaia G, Nicholson GC, Nuti R, Papapoulos S, Montes J, Ratajczak T, Rea SL, Rendina D, Gonzalez-Sarmiento R, Di Stefano M, Ward LC, Walsh JP, Ralston SH; Genetic Determinants of Paget\u2019s Disease (GDPD) Consortium (2011) Genome-wide association identifies three new susceptibility loci for Paget\u2019s disease of bone. Nat Genet 43:685\u2013689. https:\/\/doi.org\/10.1038\/ng.845","journal-title":"Nat Genet"},{"key":"522_CR74","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1084\/jem.20040518","volume":"200","author":"T Kukita","year":"2004","unstructured":"Kukita T, Wada N, Kukita A, Kakimoto T, Sandra F, Toh K, Nagata K, Iijima T, Horiuchi M, Matsusaki H, Hieshima K, Yoshie O, Nomiyama H (2004) RANKL-induced DC-STAMP is essential for osteoclastogenesis. J Exp Med 200:941\u2013946. https:\/\/doi.org\/10.1084\/jem.20040518","journal-title":"J Exp Med"},{"key":"522_CR75","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1084\/jem.20050645","volume":"202","author":"M Yagi","year":"2005","unstructured":"Yagi M, Miyamoto T, Sawatani Y, Iwamoto K, Hosogane N, Fujita N, Morita K, Ninomiya K, Suzuki T, Miyamoto K, Oike Y, Takeya M, Toyama Y, Suda T (2005) DC-STAMP is essential for cell-cell fusion in osteoclasts and foreign body giant cells. J Exp Med 202:345\u2013351. https:\/\/doi.org\/10.1084\/jem.20050645","journal-title":"J Exp Med"},{"key":"522_CR76","doi-asserted-by":"publisher","first-page":"1438","DOI":"10.1016\/j.cub.2007.07.041","volume":"17","author":"G Zhu","year":"2007","unstructured":"Zhu G, Wu CJ, Zhao Y, Ashwell JD (2007) Optineurin negatively regulates TNFalpha- induced NF-kappaB activation by competing with NEMO for ubiquitinated RIP. Curr Biol 17:1438\u20131443. https:\/\/doi.org\/10.1016\/j.cub.2007.07.041","journal-title":"Curr Biol"},{"key":"522_CR77","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1016\/j.celrep.2015.09.071","volume":"13","author":"R Obaid","year":"2015","unstructured":"Obaid R, Wani S, Azfer A, Hurd T, Jones R, Cohen P, Ralston SH, Albagha OME (2015) Optineurin negatively regulates osteoclast differentiation by modulating NFkB and interferon signalling; implication for Paget\u2019s disease. Cell Rep 13:1096\u20131102. https:\/\/doi.org\/10.1016\/j.celrep.2015.09.071","journal-title":"Cell Rep"},{"key":"522_CR78","doi-asserted-by":"publisher","first-page":"3286","DOI":"10.1093\/hmg\/ddv068","volume":"24","author":"M Vallet","year":"2015","unstructured":"Vallet M, Soares DC, Wani S, Sophocleous A, Warner J, Salter DM, Ralston SH, Albagha OM (2015) Targeted sequencing of the Paget\u2019s disease associated 14q32 locus identifies several missense coding variants in RIN3 that predispose to Paget\u2019s disease of bone. Hum Mol Genet 24:3286\u20133295. https:\/\/doi.org\/10.1093\/hmg\/ddv068","journal-title":"Hum Mol Genet"},{"key":"522_CR79","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1002\/jbmr.542","volume":"27","author":"F Gianfrancesco","year":"2012","unstructured":"Gianfrancesco F, Rendina D, Di Stefano M, Mingione A, Esposito T, Merlotti D, Gallone S, Magliocca S, Goode A, Formicola D, Morello G, Layfield R, Frattini A, De Filippo G, Nuti R, Searle M, Strazzullo P, Isaia G, Mossetti G, Gennari L (2012) A nonsynonymous TNFRSF11A variation increases NF\u03baB activity and the severity of Paget\u2019s disease. J Bone Miner Res 27:443\u2013452. https:\/\/doi.org\/10.1002\/jbmr.542","journal-title":"J Bone Miner Res"},{"key":"522_CR80","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.ajhg.2015.12.016","volume":"98","author":"G Divisato","year":"2016","unstructured":"Divisato G, Formicola D, Esposito T, Merlotti D, Pazzaglia L, Del Fattore A, Siris E, Orcel P, Brown JP, Nuti R, Strazzullo P, Benassi MS, Cancela ML, Michou L, Rendina D, Gennari L, Gianfrancesco F (2016) ZNF687 mutations in severe Paget disease of bone associated with giant cell tumor. Am J Hum Genet 98:275\u2013286. https:\/\/doi.org\/10.1016\/j.ajhg.2015.12.016","journal-title":"Am J Hum Genet"},{"key":"522_CR81","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1016\/j.cell.2011.05.006","volume":"145","author":"A Malovannaya","year":"2011","unstructured":"Malovannaya A, Lanz RB, Jung SY, Bulynko Y, Le NT, Chan DW, Ding C, Shi Y, Yucer N, Krenciute G, Kim BJ, Li C, Chen R, Li W, Wang Y, O\u2019Malley BW, Qin J (2011) Analysis of the human endogenous coregulator complexome. Cell 145:787\u2013799. https:\/\/doi.org\/10.1016\/j.cell.2011.05.006","journal-title":"Cell"},{"key":"522_CR82","doi-asserted-by":"publisher","DOI":"10.1038\/emm.2017.64","author":"B Lu","year":"2017","unstructured":"Lu B, Jiao Y, Wang Y, Dong J, Wei M, Cui B, Sun Y, Wang L, Zhang B, Chen Z, Zhao Y (2017) A FKBP5 mutation is associated with Paget\u2019s disease of bone and enhances osteoclastogenesis. Exp Mol Med. https:\/\/doi.org\/10.1038\/emm.2017.64","journal-title":"Exp Mol Med"},{"key":"522_CR83","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1038\/ncb1086","volume":"6","author":"T Bouwmeester","year":"2004","unstructured":"Bouwmeester T, Bauch A, Ruffner H, Angrand PO, Bergamini G, Croughton K, Cruciat C, Eberhard D, Gagneur J, Ghidelli S, Hopf C, Huhse B, Mangano R, Michon AM, Schirle M, Schlegl J, Schwab M, Stein MA, Bauer A, Casari G, Drewes G, Gavin AC, Jackson DB, Joberty G, Neubauer G, Rick J, Kuster B, Superti-Furga G (2004) A physical and functional map of the human TNF-alpha\/NF-kappa B signal transduction pathway. Nat Cell Biol 6:97\u2013105. https:\/\/doi.org\/10.1038\/ncb1086","journal-title":"Nat Cell Biol"},{"key":"522_CR84","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1126\/science.959849","volume":"194","author":"BG Mills","year":"1976","unstructured":"Mills BG, Singer FR (1976) Nuclear inclusions in Paget\u2019s disease of bone. Science 194:201\u2013202","journal-title":"Science"},{"key":"522_CR85","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1002\/bies.950151203","volume":"15","author":"AP Mee","year":"1993","unstructured":"Mee AP, Sharpe PT (1993) Dogs, distemper and Paget\u2019s disease. Bioessays 15:783\u2013789. https:\/\/doi.org\/10.1002\/bies.950151203","journal-title":"Bioessays"},{"key":"522_CR86","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1097\/00001648-199705000-00004","volume":"8","author":"G L\u00f3pez-Abente","year":"1997","unstructured":"L\u00f3pez-Abente G, Morales-Piga A, Elena-Ib\u00e1\u00f1ez A, Rey-Rey JS, Corres-Gonz\u00e1lez J (1997) Cattle, pets, and Paget\u2019s disease of bone. Epidemiology 8:247\u2013251","journal-title":"Epidemiology"},{"key":"522_CR87","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1097\/00003086-198403000-00044","volume":"183","author":"BG Mills","year":"1984","unstructured":"Mills BG, Singer FR, Weiner LP, Suffin SC, Stabile E, Holst P (1984) Evidence for both respiratory syncytial virus and measles virus antigens in the osteoclasts of patients with Paget\u2019s disease of bone. Clin Orthop Relat Res 183:303\u2013311","journal-title":"Clin Orthop Relat Res"},{"key":"522_CR88","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1002\/jbmr.5650061115","volume":"6","author":"SH Ralston","year":"1991","unstructured":"Ralston SH, Digiovine FS, Gallacher SJ, Boyle IT, Duff GW (1991) Failure to detect paramyxovirus sequences in Paget\u2019s disease of bone using polymerase chain reaction. J Bone Miner Res 6:1243\u20131248. https:\/\/doi.org\/10.1002\/jbmr.5650061115","journal-title":"J Bone Miner Res"},{"key":"522_CR89","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1002\/jbmr.5650090103","volume":"9","author":"MA Birch","year":"1994","unstructured":"Birch MA, Taylor W, Fraser WD, Ralston SH, Hart CA, Gallagher JA (1994) Absence of paramyxovirus RNA in cultures of pagetic bone cells and in pagetic bone. J Bone Miner Res 9:11\u201316. https:\/\/doi.org\/10.1002\/jbmr.5650090103","journal-title":"J Bone Miner Res"},{"key":"522_CR90","doi-asserted-by":"publisher","first-page":"1602","DOI":"10.1002\/jbmr.5650111103","volume":"11","author":"SV Reddy","year":"1996","unstructured":"Reddy SV, Singer FR, Mallette L, Roodman GD (1996) Detection of measles virus nucleocapsid transcripts in circulating blood cells from patients with Paget disease. J Bone Miner Res 11:1602\u20131607. https:\/\/doi.org\/10.1002\/jbmr.5650111103","journal-title":"J Bone Miner Res"},{"key":"522_CR91","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/S8756-3282(98)00079-9","volume":"23","author":"AP Mee","year":"1998","unstructured":"Mee AP, Dixon JA, Hoyland JA, Davies M, Selby PL, Mawer EB (1998) Detection of canine distemper virus in 100% of Paget\u2019s disease samples by in situ-reverse transcriptase-polymerase chain reaction. Bone 23:171\u2013175","journal-title":"Bone"},{"key":"522_CR92","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/0049-0172(94)90042-6","volume":"23","author":"MT Gordon","year":"1994","unstructured":"Gordon MT, Mee AP, Sharpe PT (1994) Paramyxoviruses in Paget\u2019s disease. Semin Arthritis Rheum 23:232\u2013234","journal-title":"Semin Arthritis Rheum"},{"key":"522_CR93","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/S8756-3282(00)00343-4","volume":"27","author":"CG Ooi","year":"2000","unstructured":"Ooi CG, Walsh CA, Gallagher JA, Fraser WD (2000) Absence of measles virus and canine distemper virus transcripts in long-term bone marrow cultures from patients with Paget\u2019s disease of bone. Bone 27:417\u2013421","journal-title":"Bone"},{"key":"522_CR94","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1359\/jbmr.070103","volume":"22","author":"SH Ralston","year":"2007","unstructured":"Ralston SH, Afzal MA, Helfrich MH, Fraser WD, Gallagher JA, Mee A, Rima B (2007) Multicenter blinded analysis of RT-PCR detection methods for paramyxoviruses in relation to Paget\u2019s disease of bone. J Bone Miner Res 22:569\u2013577. https:\/\/doi.org\/10.1359\/jbmr.070103","journal-title":"J Bone Miner Res"},{"key":"522_CR95","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1002\/jcb.25291","volume":"117","author":"M Vallet","year":"2016","unstructured":"Vallet M, Ralston SH (2016) Biology and treatment of Paget\u2019s disease of bone. J Cell Biochem 117:289\u2013299. https:\/\/doi.org\/10.1002\/jcb.25291","journal-title":"J Cell Biochem"},{"key":"522_CR96","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1172\/JCI8489","volume":"105","author":"N Kurihara","year":"2000","unstructured":"Kurihara N, Reddy SV, Menaa C, Anderson D, Roodman GD (2000) Osteoclasts expressing the measles virus nucleocapsid gene display pagetic phenotype. J Clin Invest 105:607\u2013614. https:\/\/doi.org\/10.1172\/JCI8489","journal-title":"J Clin Invest"},{"key":"522_CR97","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/0169-6009(92)90923-2","volume":"19","author":"MT Gordon","year":"1992","unstructured":"Gordon MT, Mee AP, Anderson DC, Sharpe PT (1992) Canine distemper virus transcripts sequenced from pagetic bone. Bone Miner 19:159\u2013174","journal-title":"Bone Miner"},{"key":"522_CR98","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1359\/JBMR.051108","volume":"21","author":"N Kurihara","year":"2006","unstructured":"Kurihara N, Zhou H, Reddy SV, Garcia Palacios V, Subler MA, Dempster DW, Windle JJ, Roodman GD (2006) Expression of measles virus nucleocapsid protein in osteoclasts induces Paget\u2019s disease-like bone lesions in mice. J Bone Miner Res 21:446\u2013455. https:\/\/doi.org\/10.1359\/JBMR.051108","journal-title":"J Bone Miner Res"},{"key":"522_CR99","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1172\/JCI82012","volume":"126","author":"J Teramachi","year":"2016","unstructured":"Teramachi J, Nagata Y, Mohammad K, Inagaki Y, Ohata Y, Guise T, Michou L, Brown JP, Windle JJ, Kurihara N, Roodman GD (2016) Measles virus nucleocapsid protein increases osteoblast differentiation in Paget\u2019s disease. J Clin Invest 126:1012\u20131022. https:\/\/doi.org\/10.1172\/JCI82012","journal-title":"J Clin Invest"},{"key":"522_CR100","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1111\/cen.12741","volume":"83","author":"T Cundy","year":"2015","unstructured":"Cundy T, Rutland MD, Naot D, Bolland M (2015) Evolution of Paget\u2019s disease of bone in adults inheriting SQSTM1 mutations. Clin Endocrinol 83:315\u2013319. https:\/\/doi.org\/10.1111\/cen.12741","journal-title":"Clin Endocrinol"},{"key":"522_CR101","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1136\/bmj.1.6168.931","volume":"1","author":"LR Solomon","year":"1979","unstructured":"Solomon LR (1979) Billiard-player\u2019s fingers: an unusual case of Paget\u2019s disease of bone. Br Med J 1:931","journal-title":"Br Med J"},{"key":"522_CR102","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.jbspin.2011.07.005","volume":"79","author":"L Michou","year":"2012","unstructured":"Michou L, Collet C, Morissette J, Audran M, Thomas T, Gagnon E, Launay JM, Laplanche JL, Brown JP, Orcel P (2012) Epidemiogenetic study of French families with Paget\u2019s disease of bone. Joint Bone Spine 79:393\u2013398. https:\/\/doi.org\/10.1016\/j.jbspin.2011.07.005","journal-title":"Joint Bone Spine"},{"key":"522_CR103","first-page":"226","volume":"28","author":"DJ Barker","year":"1974","unstructured":"Barker DJ, Gardner MJ (1974) Distribution of Paget\u2019s disease in England, Wales and Scotland and a possible relationship with vitamin D deficiency in childhood. Br J Prev Soc Med 28:226\u2013232","journal-title":"Br J Prev Soc Med"},{"key":"522_CR104","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1016\/S8756-3282(02)00833-5","volume":"31","author":"JH Lever","year":"2002","unstructured":"Lever JH (2002) Paget\u2019s disease of bone in Lancashire and arsenic pesticide in cotton mill wastewater: a speculative hypothesis. Bone 31:434\u2013436","journal-title":"Bone"},{"key":"522_CR105","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1016\/j.jbspin.2016.11.010","volume":"84","author":"MC Audet","year":"2017","unstructured":"Audet MC, Jean S, Beaudoin C, Guay-B\u00e9langer S, Dumont J, Brown JP, Michou L (2017) Environmental factors associated with familial or non-familial forms of Paget\u2019s disease of bone. Joint Bone Spine 84:719\u2013723. https:\/\/doi.org\/10.1016\/j.jbspin.2016.11.010","journal-title":"Joint Bone Spine"},{"issue":"7548","key":"522_CR106","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1016\/S0140-6736(68)90236-5","volume":"1","author":"OL Bijvoet","year":"1968","unstructured":"Bijvoet OL, van der Sluys Veer J, Jansen AP (1968) Effects of calcitonin on patients with Paget\u2019s disease, thyrotoxicosis, or hypercalcaemia. Lancet 1(7548):876\u2013881","journal-title":"Lancet"},{"key":"522_CR107","doi-asserted-by":"publisher","first-page":"107","DOI":"10.2147\/OARRR.S4504","volume":"1","author":"D Merlotti","year":"2009","unstructured":"Merlotti D, Gennari L, Martini G, Nuti R (2009) Current options for the treatment of Paget\u2019s disease of the bone. Open Access Rheumatol 1:107\u2013120","journal-title":"Open Access Rheumatol"},{"key":"522_CR108","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004956.pub3","author":"L Corral-Gudino","year":"2017","unstructured":"Corral-Gudino L, Tan AJ, Del Pino-Montes J, Ralston SH (2017) Bisphosphonates for Paget\u2019s disease of bone in adults. Cochrane Database Syst Rev. https:\/\/doi.org\/10.1002\/14651858.CD004956.pub3","journal-title":"Cochrane Database Syst Rev"},{"key":"522_CR109","doi-asserted-by":"publisher","first-page":"P94","DOI":"10.1359\/jbmr.06s218","volume":"21","author":"ES Siris","year":"2006","unstructured":"Siris ES, Lyles KW, Singer FR, Meunier PJ (2006) Medical management of Paget\u2019s disease of bone: implications for treatment and review of current therapies. J Bone Miner Res 21:P94\u2013P97. https:\/\/doi.org\/10.1359\/jbmr.06s218","journal-title":"J Bone Miner Res"},{"key":"522_CR110","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.2174\/138955709788922683","volume":"9","author":"L Gennari","year":"2009","unstructured":"Gennari L, Merlotti D, Mossetti G, Rendina D, De Paola V, Martini G, Nuti R (2009) The use of intravenous aminobisphosphonates for the treatment of Paget\u2019s disease of bone. Mini Rev Med Chem 9:1052\u20131063","journal-title":"Mini Rev Med Chem"},{"key":"522_CR111","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/S8756-3282(02)00817-7","volume":"31","author":"PL Selby","year":"2002","unstructured":"Selby PL, Davie MWJ, Ralston SH, Stone MD (2002) Guidelines on the management of Paget\u2019s disease of bone. Bone 31:366\u2013373","journal-title":"Bone"},{"key":"522_CR112","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1359\/jbmr.1997.12.4.691","volume":"12","author":"ES Siris","year":"1997","unstructured":"Siris ES, Feldman F (1997) Natural history of untreated Paget\u2019s disease of the tibia. J Bone Miner Res 12:691\u2013692. https:\/\/doi.org\/10.1359\/jbmr.1997.12.4.691","journal-title":"J Bone Miner Res"},{"key":"522_CR113","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1259\/0007-1285-60-717-849","volume":"60","author":"GW Dodd","year":"1987","unstructured":"Dodd GW, Ibbertson HK, Fraser TR, Holdaway IM, Wattie D (1987) Radiological assessment of Paget\u2019s disease of bone after treatment with the bisphosphonates EHDP and APD. Br J Radiol 60:849\u2013860","journal-title":"Br J Radiol"},{"key":"522_CR114","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/S0002-9343(96)00227-6","volume":"101","author":"IR Reid","year":"1996","unstructured":"Reid IR, Nicholson GC, Weinstein RS, Hosking DJ, Cundy T, Kotowicz MA, Murphy WA Jr, Yeap S, Dufresne S, Lombardi A, Musliner TA, Thompson DE, Yates AJ (1996) Biochemical and radiologic improvement in Paget\u2019s disease of bone treated with alendronate: a randomized, placebo-controlled trial. Am J Med 101:341\u2013348","journal-title":"Am J Med"},{"key":"522_CR115","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/S8756-3282(96)00224-4","volume":"19","author":"DH Gutteridge","year":"1996","unstructured":"Gutteridge DH, Retallack RW, Ward LC, Stuckey BG, Stewart GO, Prince RL, Kent GN, Bhagat CI, Price RI, Thompson RI, Nicholson GC (1996) Clinical, biochemical, hematologic, and radiographic responses in Paget\u2019s disease following intravenous pamidronate disodium: a 2-year study. Bone 19:387\u2013394","journal-title":"Bone"},{"key":"522_CR116","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/S8756-3282(99)00271-9","volume":"26","author":"JP Brown","year":"2000","unstructured":"Brown JP, Chines AA, Myers WR, Eusebio RA, Ritter-Hrncirik C, Hayes CW (2000) Improvement of pagetic bone lesions with risedronate treatment: a radiologic study. Bone 26:263\u2013267","journal-title":"Bone"},{"key":"522_CR117","first-page":"206","volume":"25","author":"P Peris","year":"2007","unstructured":"Peris P, Alvarez L, Vidal S, Mart\u00ednez MA, Monegal A, Gua\u00f1abens N (2007) Treatment with tiludronate has a similar effect to risedronate on Paget\u2019s disease activity assessed by bone markers and bone scintigraphy. Clin Exp Rheumatol 25:206\u2013210","journal-title":"Clin Exp Rheumatol"},{"key":"522_CR118","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1210\/jcem.81.3.8772558","volume":"81","author":"E Siris","year":"1996","unstructured":"Siris E, Weinstein RS, Altman R, Conte JM, Favus M, Lombardi A, Lyles K, McIlwain H, Murphy WA Jr, Reda C, Rude R, Seton M, Tiegs R, Thompson D, Tucci JR, Yates AJ, Zimering M (1996) Comparative study of alendronate versus etidronate for the treatment of Paget\u2019s disease of bone. J Clin Endocrinol Metab 81:961\u2013967. https:\/\/doi.org\/10.1210\/jcem.81.3.8772558","journal-title":"J Clin Endocrinol Metab"},{"key":"522_CR119","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1302\/0301-620X.72B1.2137127","volume":"72","author":"DR Bickerstaff","year":"1990","unstructured":"Bickerstaff DR, Douglas DL, Burke PH, O\u2019Doherty DP, Kanis JA (1990) Improvement in facial deformity of Paget disease treated with diphosphonates. J Bone Joint Surg Br 72:132\u2013136","journal-title":"J Bone Joint Surg Br"},{"key":"522_CR120","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1258\/jrsm.98.6.272","volume":"98","author":"LM Murdin","year":"2005","unstructured":"Murdin LM, Yeoh LH (2005) Hearing loss treated with pamidronate. J R Soc Med 98:272\u2013274. https:\/\/doi.org\/10.1258\/jrsm.98.6.272","journal-title":"J R Soc Med"},{"key":"522_CR121","doi-asserted-by":"publisher","first-page":"489S","DOI":"10.1016\/8756-3282(95)00260-2","volume":"17","author":"PJ Meunier","year":"1995","unstructured":"Meunier PJ, Vignot E (1995) Therapeutic strategy in Paget\u2019s disease of bone. Bone 17:489S\u2013491S","journal-title":"Bone"},{"key":"522_CR122","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1002\/jbmr.1750","volume":"28","author":"F Gianfrancesco","year":"2013","unstructured":"Gianfrancesco F, Rendina D, Merlotti D, Esposito T, Amyere M, Formicola D, Muscariello R, De Filippo G, Strazzullo P, Nuti R, Vikkula M, Gennari L (2013) Giant cell tumor occurring in familial Paget\u2019s disease of bone: report of clinical characteristics and linkage analysis of a large pedigree. J Bone Miner Res 28:341\u2013350. https:\/\/doi.org\/10.1002\/jbmr.1750","journal-title":"J Bone Miner Res"},{"key":"522_CR123","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1359\/jbmr.090709","volume":"25","author":"AL Langston","year":"2010","unstructured":"Langston AL, Campbell MK, Fraser WD, MacLennan GS, Selby PL, Ralston SH, PRISM Trial Group (2010) Randomized trial of intensive bisphosphonate treatment versus symptomatic management in Paget\u2019s disease of bone. J Bone Miner Res 25:20\u201331. https:\/\/doi.org\/10.1359\/jbmr.090709","journal-title":"J Bone Miner Res"},{"key":"522_CR124","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1002\/jbmr.3066","volume":"32","author":"A Tan","year":"2017","unstructured":"Tan A, Goodman K, Walker A, Hudson J, MacLennan GS, Selby PL, Fraser WD, Ralston SH, PRISM-EZ Trial Group (2017) Long-term randomized trial of intensive versus symptomatic management in Paget\u2019s disease of bone: the PRISM-EZ study. J Bone Miner Res 32:1165\u20131173. https:\/\/doi.org\/10.1002\/jbmr.3066","journal-title":"J Bone Miner Res"},{"key":"522_CR125","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1002\/jbmr.3156","volume":"32","author":"T Cundy","year":"2017","unstructured":"Cundy T (2017) Treating Paget\u2019s disease\u2014why and how much? J Bone Miner Res 32:1163\u20131164. https:\/\/doi.org\/10.1002\/jbmr.3156","journal-title":"J Bone Miner Res"},{"key":"522_CR126","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1359\/jbmr.06s216","volume":"21","author":"SE Papapoulos","year":"2006","unstructured":"Papapoulos SE, Eekhoff EM, Zwinderman AH (2006) Acquired resistance to bisphosphonates in Paget\u2019s disease of bone. J Bone Miner Res 21:88\u201391. https:\/\/doi.org\/10.1359\/jbmr.06s216","journal-title":"J Bone Miner Res"},{"key":"522_CR127","doi-asserted-by":"publisher","first-page":"1510","DOI":"10.1359\/jbmr.070704","volume":"22","author":"D Merlotti","year":"2007","unstructured":"Merlotti D, Gennari L, Martini G, Valleggi F, De Paola V, Avanzati A, Nuti R (2007) Comparison of different intravenous bisphosphonate regimens for Paget\u2019s disease of bone. J Bone Miner Res 22:1510\u20131517. https:\/\/doi.org\/10.1359\/jbmr.070704","journal-title":"J Bone Miner Res"},{"key":"522_CR128","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1136\/ard.57.9.572","volume":"57","author":"HM Buckler","year":"1998","unstructured":"Buckler HM, Mercer SJ, Davison CE (1998) Evaluation of adverse experiences related to pamidronate infusion in Paget disease of bone. Ann Rheum Dis 57:572","journal-title":"Ann Rheum Dis"},{"key":"522_CR129","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1056\/NEJMoa044241","volume":"353","author":"IR Reid","year":"2005","unstructured":"Reid IR, Miller P, Lyles K, Fraser W, Brown JP, Saidi Y, Mesenbrink P, Su G, Pak J, Zelenakas K, Luchi M, Richardson P, Hosking D (2005) Comparison of a single infusion of zoledronic acid with risedronate for Paget\u2019s disease. N Engl J Med 353:898\u2013908. https:\/\/doi.org\/10.1056\/NEJMoa044241","journal-title":"N Engl J Med"},{"key":"522_CR130","doi-asserted-by":"publisher","first-page":"2261","DOI":"10.1002\/jbmr.438","volume":"26","author":"IR Reid","year":"2011","unstructured":"Reid IR, Lyles K, Su G, Brown JP, Walsh JP, del Pino-Montes J, Miller PD, Fraser WD, Cafoncelli S, Bucci-Rechtweg C, Hosking DJ (2011) A single infusion of zoledronic acid produces sustained remissions in Paget disease: data to 6.5 years. J Bone Miner Res 26:2261\u20132270. https:\/\/doi.org\/10.1002\/jbmr.438","journal-title":"J Bone Miner Res"},{"key":"522_CR131","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1002\/jbmr.3029","volume":"32","author":"T Cundy","year":"2017","unstructured":"Cundy T, Maslowski K, Grey A, Reid IR (2017) Durability of response to zoledronate treatment and competing mortality in Paget\u2019s disease of bone. J Bone Miner Res 32:753\u2013756. https:\/\/doi.org\/10.1002\/jbmr.3029","journal-title":"J Bone Miner Res"},{"key":"522_CR132","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1002\/jbmr.237","volume":"26","author":"D Merlotti","year":"2011","unstructured":"Merlotti D, Rendina D, Gennari L, Mossetti G, Gianfrancesco F, Martini G, De Filippo G, Avanzati A, Franci B, Campagna MS, Strazzullo P, Nuti R (2011) Comparison of intravenous and intramuscular neridronate regimens for the treatment of Paget disease of bone. J Bone Miner Res 26:512\u2013518. https:\/\/doi.org\/10.1002\/jbmr.237","journal-title":"J Bone Miner Res"},{"key":"522_CR133","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1007\/s00223-016-0214-7","volume":"100","author":"IR Reid","year":"2017","unstructured":"Reid IR, Wattie D, Gamble GD, Kalluru R, Cundy T (2017) Long-term effects of intravenous ibandronate in Paget\u2019s disease of bone. Calcif Tissue Int 100:250\u2013254. https:\/\/doi.org\/10.1007\/s00223-016-0214-7","journal-title":"Calcif Tissue Int"},{"key":"522_CR134","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1007\/s00223-016-0150-6","volume":"99","author":"IR Reid","year":"2016","unstructured":"Reid IR, Sharma S, Kalluru R, Eagleton C (2016) Treatment of Paget\u2019s disease of bone with denosumab: case report and literature review. Calcif Tissue Int 99:322\u2013325. https:\/\/doi.org\/10.1007\/s00223-016-0150-6","journal-title":"Calcif Tissue Int"},{"key":"522_CR135","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1002\/art.1780231020","volume":"23","author":"C Nagant Deuxchaisnes De","year":"1980","unstructured":"De Nagant Deuxchaisnes C, Maldague B, Malghem J, Devogelaer JP, Huaux JP, Rombouts-Lindemans C (1980) The action of the main therapeutic regimens on Paget\u2019s disease of bone, with a note on the effect of vitamin D deficiency. Arthritis Rheum 23:1215\u20131234","journal-title":"Arthritis Rheum"},{"key":"522_CR136","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1212\/WNL.29.4.448","volume":"29","author":"JR Chen","year":"1979","unstructured":"Chen JR, Rhee RS, Wallach S, Avramides A, Flores A (1979) Neurologic disturbances in Paget disease of bone: response to calcitonin. Neurology 29:448\u2013457","journal-title":"Neurology"},{"key":"522_CR137","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.1001\/archinte.1995.00430160167017","volume":"155","author":"E Wallace","year":"1995","unstructured":"Wallace E, Wong J, Reid IR (1995) Pamidronate treatment of the neurologic sequelae of pagetic spinal stenosis. Arch Intern Med 155:1813\u20131815","journal-title":"Arch Intern Med"}],"container-title":["Calcified Tissue International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00223-019-00522-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00223-019-00522-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00223-019-00522-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,10]],"date-time":"2022-09-10T17:40:10Z","timestamp":1662831610000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00223-019-00522-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,23]]},"references-count":137,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019,5]]}},"alternative-id":["522"],"URL":"https:\/\/doi.org\/10.1007\/s00223-019-00522-3","relation":{},"ISSN":["0171-967X","1432-0827"],"issn-type":[{"value":"0171-967X","type":"print"},{"value":"1432-0827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,23]]},"assertion":[{"value":"7 October 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 December 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 January 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"Luigi Gennari, Domenico Rendina, Alberto Falchetti, and Daniela Merlotti declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}